Cohance Lifesciences Ltd (COHANCE) Q4FY26 Management Mirror - Mar-2026 Qtr
FY27 Financial Outlook
Management explicitly declined to provide specific financial or margin targets for the fiscal year ending Mar'27, shifting from earlier quarters (Sep'25 and Dec'25 Qtr) where a return to overall growth was anticipated; the business is now expected to bottom out with weak revenue and EBITDA in the Jun'26 Qtr before stabilizing in the Sep'26 Qtr and recovering in the second half. [Status: Withdrawn]
3 more themes on the ELITE plan.